Antibody Development For Any Target
Antibody Development For Any Target
Antibody Development For Any Target
OVERVIEW CONCEPT VALIDATION SPECIFICATIONS RESOURCES
OVERVIEW

The Twist Hyperimmune Library synthetically mimics the human in vivo antibody repertoire, providing optimal diversity for antibody development against any target.

This naïve library is the original design of the Twist Hyperimmune Library series, which also includes the VHH hShuffle Hyperimmune (HI) and Common Light Chain Hyperimmune libraries. 

Optimal Diversity
Optimal Diversity
Fully human antibody sequences
Improved diversity
Based on NGS sequencing of human naïve B and memory B cell receptors
2.5 million human HCDR3 regions represented
Precisely Designed
Precisely Designed
Proven, highly manufacturable framework
Superior binding affinity and specificity
Access to a precisely designed library
Applications
Applications
Antibody development and optimization
Targeted drug discovery
Therapeutic development for treating antibody-mediated disease or disorders
LIBRARIES FOR THERAPEUTIC DEVELOPMENT

Learn more about developing diverse synthetic fully human antibody libraries for antiviral therapeutic development.

Read the Product Sheet

The Twist Hyperimmune Library synthetically mimics the human in vivo antibody repertoire, providing optimal diversity for antibody development against any target.

This naïve library is the original design of the Twist Hyperimmune Library series, which also includes the VHH hShuffle Hyperimmune (HI) and Common Light Chain Hyperimmune libraries. 

Optimal Diversity
Optimal Diversity
Fully human antibody sequences
Improved diversity
Based on NGS sequencing of human naïve B and memory B cell receptors
2.5 million human HCDR3 regions represented
Precisely Designed
Precisely Designed
Proven, highly manufacturable framework
Superior binding affinity and specificity
Access to a precisely designed library
Applications
Applications
Antibody development and optimization
Targeted drug discovery
Therapeutic development for treating antibody-mediated disease or disorders
LIBRARIES FOR THERAPEUTIC DEVELOPMENT

Learn more about developing diverse synthetic fully human antibody libraries for antiviral therapeutic development.

Read the Product Sheet

Concept Validation
Proof of Concept Data

Twist’s Hyperimmune Library was panned against the SARS-CoV-2 S1 Spike antigen. A large number of unique clones including TB182-3, -4, and -7, were identified possessing a range of binding affinities. Their activities were demonstrated in competition and functional studies.

Twist CoV Antibody MOA
Library Panning and Screening: Panning to Functional Assays Using Full-Length IgG

This diverse Hyperimmune Library is screened against target antigens. Functional antibodies can be obtained in 8+ weeks.

figure
Anti-S1 mAbs Kinetics, SARS-CoV-2 (Top Leads): Direct Coupled Antibodies

Twist’s Hyperimmune Library has been effective at uncovering SARS-CoV-2 S1 Protein virus leads as well as broad CD3e
discovery effort.

graphs
S1 RBD: VERO E6 Inhibition by FACS

TB182-3 and TB-182-4 Show Potent Inhibition of S1 Binding to ACE2-expressing VERO E6 cells.

S1 RBD: VERO E6 Inhibition by FACS
Proof of Concept Data

Twist’s Hyperimmune Library was panned against the SARS-CoV-2 S1 Spike antigen. A large number of unique clones including TB182-3, -4, and -7, were identified possessing a range of binding affinities. Their activities were demonstrated in competition and functional studies.

Twist CoV Antibody MOA
Library Panning and Screening: Panning to Functional Assays Using Full-Length IgG

This diverse Hyperimmune Library is screened against target antigens. Functional antibodies can be obtained in 8+ weeks.

figure
Anti-S1 mAbs Kinetics, SARS-CoV-2 (Top Leads): Direct Coupled Antibodies

Twist’s Hyperimmune Library has been effective at uncovering SARS-CoV-2 S1 Protein virus leads as well as broad CD3e
discovery effort.

graphs
S1 RBD: VERO E6 Inhibition by FACS

TB182-3 and TB-182-4 Show Potent Inhibition of S1 Binding to ACE2-expressing VERO E6 cells.

S1 RBD: VERO E6 Inhibition by FACS
SPECIFICATIONS
Specifications

A synthetic phage antibody library was derived from public databases of naïve and memory B-cell receptor sequences from three human donors. More than two million HCDR3 sequences were gathered and constructed with Twist’s DNA synthesis capabilities.

  • Humanized DP-47 framework
  • > 2 million human CDR3 sequences
  • Highly functional Fab library
  • Final library diversity = 1 x 1010
     
Specifications
Specifications

A synthetic phage antibody library was derived from public databases of naïve and memory B-cell receptor sequences from three human donors. More than two million HCDR3 sequences were gathered and constructed with Twist’s DNA synthesis capabilities.

  • Humanized DP-47 framework
  • > 2 million human CDR3 sequences
  • Highly functional Fab library
  • Final library diversity = 1 x 1010
     
Specifications
RESOURCES